Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Merck
Dow
McKesson
Teva
Colorcon
McKinsey
Medtronic

Generated: May 26, 2018

DrugPatentWatch Database Preview

CYCLOCORT Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Cyclocort patents expire, and when can generic versions of Cyclocort launch?

Cyclocort is a drug marketed by Astellas and is included in three NDAs.

The generic ingredient in CYCLOCORT is amcinonide. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amcinonide profile page.
Summary for CYCLOCORT
Drug patent expirations by year for CYCLOCORT
Synonyms for CYCLOCORT
(11?,16?)-21-(Acetyloxy)-16,17-[cyclopentylidenebis(oxy)]-9-fluoro-11-hydroxypregna-1,4-diene-3,20-dione
1,4-Pregnadiene-2,20-dione-16,17-cyclopentylidenedioxy-9-fluoro-11,21-dihydroxy-21-acetate
16alpha,17alpha-(cyclopentane-1,1-diyldioxy)-9-fluoro-11beta-hydroxy-3,20-dioxopregna-1,4-dien-21-yl acetate
19alpha-Fluor-11beta,21-dihydroxy-16alpha,17alpha-(tetramethylen)methylendioxy-1,4-pregnadien-3,20-dion 21-acetat
2-[(1'S,2'S,4'R,8'S,9'S,11'S,12'R,13'S)-12'-fluoro-11'-hydroxy-9',13'-dimethyl-16'-oxo-5',7'-dioxaspiro[cyclopentane-1,6'-pentacyclo[10.8.0.0;{2,9}.0;{4,8}.0;{13,18}]icosane]-14',17'-dien-8'-yl]-2-oxoethyl acetate
423W026MA9
51022-69-6
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclopentanone, 21-acetate
AC-13190
AC1L9FH1
AKOS015961167
Amciderm
Amcinonid
amcinonida
amcinonide
Amcinonide (JAN/USP/INN)
Amcinonide [USAN:INN:BAN:JAN]
Amcinonide [USAN:USP:INN:BAN:JAN]
Amcinonide, analytical standard
Amcinonide, United States Pharmacopeia (USP) Reference Standard
Amcinonido
Amcinonido [INN-Spanish]
Amcinonidum
Amcinonidum [INN-Latin]
BRD-K13960744-001-09-7
C28H35FO7
CAS-51022-69-6
CCG-221135
CHEBI:31199
CHEMBL1200732
CL 34,699
CL 34699
CL-34699
CS-4805
Cyclocort (TN)
Cyclort
D01387
D06XHC
DB00288
DSSTox_CID_25905
DSSTox_GSID_45905
DSSTox_RID_81217
DTXSID6045905
EINECS 256-915-2
GTPL7060
HMS2235K23
HY-B1197
ILKJAFIWWBXGDU-MOGDOJJUSA-N
MLS000028656
MLS001146959
MLS001333715
MLS002695893
MolPort-003-940-103
NCGC00095071-01
Opera_ID_1472
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-16,17-(cyclopentylidenebis(oxy))-9-fluoro-11-hydroxy-, (11beta,16alpha)-
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-16,17-[cyclopentylidenebis(oxy)]-9-fluoro-11-hydroxy-, (11.beta.,16.alpha.)-
SC-81448
SCHEMBL4720
SMR000058920
SR-01000003161
SR-01000003161-2
Tox21_111411
Triamcinolonacetatcyclopentanonid
triamcinolone 16,17-cyclopentylidenedioxy-21-acetate
UNII-423W026MA9
Visderm
X1044
ZINC3977777

US Patents and Regulatory Information for CYCLOCORT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astellas CYCLOCORT amcinonide CREAM;TOPICAL 018116-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Astellas CYCLOCORT amcinonide OINTMENT;TOPICAL 018498-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Astellas CYCLOCORT amcinonide CREAM;TOPICAL 018116-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Astellas CYCLOCORT amcinonide LOTION;TOPICAL 019729-001 Jun 13, 1988 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for CYCLOCORT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astellas CYCLOCORT amcinonide CREAM;TOPICAL 018116-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Astellas CYCLOCORT amcinonide OINTMENT;TOPICAL 018498-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Merck
Accenture
QuintilesIMS
Healthtrust
Express Scripts
Citi
Moodys
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.